KEY vs PHIO · P/E 13, rev $7.51B vs $10.4M cap
KeyCorp (KEY) versus Phio Pharmaceuticals Corp (PHIO) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Phio Pharmaceuticals Corp (PHIO) is a biotechnology company listed on US.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
PHIO does not have a complete income-statement cache yet.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. PHIO currently screens at market cap $10.4M.
Not investment advice. Open the KEY and PHIO stock pages for the full models.
Not investment advice.